Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Bullboard Posts
Post by NewFanCBDon Apr 24, 2020 1:45pm
158 Views
Post# 30950444

Could Cardiol Therapeutics be the next Covid play?

Could Cardiol Therapeutics be the next Covid play?It sure sounds like it. There was a guy on BNN today saying that he bought Cardiol a couple of weeks ago and feels it's a good candidate to assist with the fight against Cobourg 19. He talked about Covid19 patients having inflammation of the heart and that cardiol has a product that can assist with that, that they are probably going to move ahead with testing on covid patients, that they have $6 million worth of inventory related to their cardiol RX product that will be going in to the shoppers drug Mart stores across Canada. I felt he was wired up on Cardiol and the stock started to move to $3.12!!!  I think this thing could hit five bucks on momentum leading up to potential trials. Just waiting for news from the company. If there was ever a stock that could pop on COVID19 news, it's thisvery stock.I love this company! Go Cardiol Go. 
Bullboard Posts